CLINICAL_TRIALS
trial_result
· 2013-05-08
Clinical Trial Update: 12-month Study of AMG 073 in Renal Osteodystrophy [Phase 2]
Summary
This update reports the completion of a 12-month Phase 2 study evaluating AMG 073 for renal osteodystrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Renal Osteodystrophy | Phase 2 | Status: COMPLETED